Erythropoietin drives breast cancer progression by activation of its receptor EPOR



Chan, Ka Kui, Matchett, Kyle B, Coulter, Jonathan A, Yuen, Hiu-Fung, McCrudden, Cian M, Zhang, Shu-Dong, Irwin, Gareth W, Davidson, Matthew A, Ruelicke, Thomas, Schober, Sophie
et al (show 8 more authors) (2017) Erythropoietin drives breast cancer progression by activation of its receptor EPOR. ONCOTARGET, 8 (24). 38251 - 38263.

[img] Text
Erythropoietin drives breast cancer progression by activation of its receptor EPOR.pdf - Published Version

Download (5MB)
Item Type: Article
Uncontrolled Keywords: EPO, EPOR, breast cancer, MYC, apoptosis
Depositing User: Symplectic Admin
Date Deposited: 23 Nov 2017 11:52
Last Modified: 17 Sep 2020 06:11
DOI: 10.18632/oncotarget.16368
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3012768